≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_GENITAL_EXALLC for full statistics.

Carcinoma in situ of other and unspecified genital organs

DOID EFO Endpoint Browser

CD2_INSITU_GENITAL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D07
  • Cause of death: ICD-10 — D07

2 out of 7 registries used, show all original rules.

312

4. Check minimum number of events

None

312

5. Include endpoints

603

6. Filter based on genotype QC (FinnGen only)

603

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D00-D09
Name in latin
Carcinoma in situ organorum genitalium aliorum sive non specificatorum

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ of other and unspecified genital organs based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 603 603 -
Unadjusted period prevalence (%) 0.21 0.21 -
Median age at first event (years) 59.66 59.66 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
548
Matched controls
5478
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ULA02
NOMESCO Finland
Kolposcopy
25.6
224.5
363
389
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
42.6
185.5
234
94
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
1053.7
164.7
153
*
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
1855.3
150.3
139
*
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
+∞
144.3
132
*
LEB00
NOMESCO Finland
Biopsy of vagina
48.8
134.5
163
47
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
11.1
129.4
301
540
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
128.3
118
*
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
114.7
106
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
66.7
98.0
112
21
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
81.2
90.1
100
15
LFC00
NOMESCO Finland
Partial excision of vulva
932.4
83.8
80
*
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
197.9
82.7
84
5
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
10.4
76.4
164
217
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
176.0
74.1
76
5
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
7.2
71.2
200
403
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
144.6
61.3
64
5
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
15.2
50.7
86
66
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
12.8
48.3
89
82
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
54.3
45.8
54
11
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
45.0
43.4
53
13
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
8.9
43.3
97
129
D06BB10
ATC
imiquimod; topical
8.9
41.5
93
123
LDA10
NOMESCO Finland
Curettage of cervix uteri
7.5
38.5
96
150
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
6.1
37.2
110
217
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
16.0
35.9
59
41
N89.0
ICD-10 Finland
Mild vaginal dysplasia
63.1
35.7
41
7
N90.0
ICD-10 Finland
Mild vulvar dysplasia
52.3
33.0
39
8
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.0
32.2
284
1447
B01AB10
ATC
tinzaparin; parenteral
5.4
31.6
102
221
N87.0
ICD-10 Finland
Mild cervical dysplasia
10.9
30.8
60
61
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
26.3
25
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.3
23.1
57
86
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
6.2
22.4
62
110
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.4
21.4
116
401
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
11.9
21.3
39
35
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
11.6
21.0
39
36
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
21.0
20
*
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
8.2
20.8
47
62
ZXC96
NOMESCO Finland
Robot assisted procedure
10.9
18.4
35
34
D07AD01
ATC
clobetasol; topical
2.7
17.6
135
583
D07.2
ICD-10 Finland
Carcinoma in situ: Vagina
+∞
16.7
16
*
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
16.7
16
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
23.9
16.6
23
10
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
15.7
15
*
D07.3
ICD-10 Finland
Carcinoma in situ: Other and unspecified female genital organs
+∞
15.7
15
*
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
164.5
15.6
16
*
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
13.6
15.3
26
20
N87.1
ICD-10 Finland
Moderate cervical dysplasia
6.9
14.9
37
57
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
11.3
14.6
27
25
N95.0
ICD-10 Finland
Postmenopausal bleeding
2.8
14.5
104
427
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.3
14.3
77
261
N90.4
ICD-10 Finland
Leukoplakia of vulva
18.1
13.9
21
12
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
13.2
91
364
128
Kela drug reimbursment
Cancers of female genital organs
5.9
12.6
35
63
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
25.0
12.5
17
7
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
47.8
11.9
14
*
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
30.8
11.7
15
5
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.6
11.6
52
153
B01AB05
ATC
enoxaparin; parenteral
2.0
11.5
198
1219
LCA06
NOMESCO Finland
Biopsy of endometrium
2.3
11.5
123
621
2333B
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]
+∞
11.5
11
*
ZXC10
NOMESCO Finland
Use of laser
6.5
11.1
28
45
N76.6
ICD-10 Finland
Ulceration of vulva
9.1
10.9
22
25
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
112.1
10.5
11
*
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
+∞
10.4
10
*
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
7.6
9.8
22
30
SPAT1312
SPAT
General health counselling
1.9
9.7
196
1261
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
13.7
9.7
16
12
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
9.4
9
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
9.8
9.3
18
19
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.6
9.2
40
116
N84.0
ICD-10 Finland
Polyp of corpus uteri
2.4
9.2
79
357
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
9.2
205
1362
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.0
9.1
28
58
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
24.5
8.9
12
5
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
8.1
8.4
18
23
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
+∞
8.4
8
*
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
+∞
8.4
8
*
E000001
ATC
NA
1.9
8.1
128
748
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
4.3
7.9
28
68
JN4AD
NOMESCO Finland
Body CT examination
2.8
7.8
50
191
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.3
7.7
38
122
WF090
NOMESCO Finland
Profylactic radiotherapy
45.6
7.7
9
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
2.7
7.7
52
204
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
8.2
7.6
16
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.6
227
1623
P01AB01
ATC
metronidazole; oral, rectal
1.7
7.5
257
1905
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
7.3
7
*
LFD00
NOMESCO Finland
Vulvectomy
+∞
7.3
7
*
J01DB01
ATC
cefalexin; oral
1.8
7.3
449
3910
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
30.4
7.2
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
7.2
73
357
LFE10
NOMESCO Finland
Plastic repair of vulva
20.3
7.2
10
5
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.1
6.9
20
40
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
6.8
89
484
SPAT1153
SPAT
Removal of sutures
1.7
6.8
182
1251
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
40.6
6.8
8
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.4
6.7
55
241
JN4BD
NOMESCO Finland
Extensive body CT
2.2
6.7
67
324
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
6.6
166
1118
D06BB04
ATC
podophyllotoxin; topical
2.9
6.6
38
136
UJF32
NOMESCO Finland
Coloscopy
1.7
6.6
152
1000
LCD11
NOMESCO Finland
Laparoscopically assisted vaginal hysterectomy
5.1
6.5
19
38
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
6.5
24
62
J02AC01
ATC
fluconazole; systemic
1.6
6.5
289
2264
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
9.4
6.3
12
13
C03CA01
ATC
furosemide; systemic
1.7
6.2
137
886
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
10.2
6.1
11
11
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
2.2
6.0
59
285

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
139
82
21.73
173.99
3.8
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
71
23
34.86
110.28
4.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
345
1279
4.97
84.42
3.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
141
271
6.49
73.56
3.3
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
427
2294
3.95
53.83
5.0
2.1
—
—
—
0
0
(4035726)
148
473
3.82
39.92
1.5
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
414
2450
3.20
39.08
4.6
3.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
176
678
3.25
35.02
9.0
6.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
27
16
17.62
32.57
1.8
1.9
ug/l
2.1
2.2
—
18
6
(40761535) Cells panel - Urine sediment
122
422
3.37
28.46
4.1
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
250
1415
2.31
21.38
5.1
4.1
estimate
0.0
0.0
0.80
64
491
(3007853) Bacteria identified in Skin by Aerobe culture
123
524
2.69
19.31
2.0
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
221
1230
2.26
19.26
5.0
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
217
1222
2.21
18.17
2.2
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
381
2676
2.15
17.83
4.9
3.8
estimate
0.0
0.0
0.80
66
484
(3044640) Blood type and Crossmatch panel - Blood
264
1626
2.11
17.38
2.4
2.1
—
—
—
0
0
(3020891) Body temperature
60
179
3.61
17.31
4.9
4.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
376
2658
2.10
16.89
5.9
5.2
estimate
0.0
0.0
0.50
61
486
(3024561) Albumin [Mass/volume] in Serum or Plasma
329
2220
2.06
16.71
5.1
4.0
g/l
36.0
35.8
0.32
305
2052
(3002256) Pathology report gross observation
139
674
2.38
16.40
1.4
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
76
288
2.88
14.74
4.1
5.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
199
1169
2.05
14.30
6.0
4.2
kg/l
1.0
1.0
0.99
19
167
(3015736) pH of Urine
299
2067
1.89
12.99
4.8
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
360
2642
1.90
12.96
4.9
3.8
estimate
0.0
0.0
0.00
63
494
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
291
2043
1.82
11.61
5.2
4.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
425
2.34
11.44
2.0
2.5
ml/min/173m2
60.8
65.9
0.69
34
173
(3003396) Base excess in Arterial blood by calculation
102
510
2.20
10.89
3.8
6.5
mmol/l
0.9
1.5
0.95
76
407
(3042936) Bacteria identified in Isolate by Culture
123
692
1.98
9.52
2.3
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
79
383
2.22
9.04
2.6
2.3
ug/l
2.7
4.8
2.86
73
329
(3026008) Bacteria identified in Urine by Culture
260
1870
1.69
8.77
3.5
3.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
315
2390
1.67
8.60
5.1
5.0
mmol/l
1.2
1.2
3.56
275
2140
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
209
1428
1.71
8.47
3.1
2.8
ng/l
1097.5
1030.3
0.09
182
1202
(3044889) 12 lead EKG panel
438
3662
1.72
7.91
4.7
3.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
380
3065
1.65
7.84
10.6
8.6
e9/l
4.0
4.0
0.01
347
2673
(3000850) Epithelial cells [#/volume] in Urine
160
1041
1.73
7.62
3.0
2.4
e6/l
6.2
8.3
0.77
138
929
(3013826) Glucose [Moles/volume] in Serum or Plasma
363
2927
1.60
7.22
4.7
4.2
mmol/l
6.6
6.5
0.08
345
2722
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
344
2756
1.58
6.89
6.8
5.3
umol/l
9.3
10.3
1.51
329
2596
(3012095) Magnesium [Moles/volume] in Serum or Plasma
126
787
1.76
6.86
2.9
2.8
mmol/l
0.8
0.8
1.39
116
723
(3003694) ABO and Rh group [Type] in Blood
191
1336
1.63
6.80
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
69
355
2.07
6.77
1.4
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
330
2632
1.56
6.64
6.0
5.9
mmol/l
1.2
1.2
4.16
274
2203
(3023368) Bacteria identified in Blood by Culture
173
1196
1.63
6.40
5.1
3.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
471
4111
1.67
6.21
9.2
6.8
u/l
78.9
77.8
0.22
450
3834
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
73
3.24
6.07
3.7
5.0
iu/ml
711.4
143.5
—
5
6
(40758558) Short blood count panel - Blood
190
1363
1.58
5.96
7.8
6.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
219
1635
1.53
5.70
3.6
2.2
u/l
53.0
56.2
0.89
206
1485
(3032080) INR in Blood by Coagulation assay
253
1952
1.51
5.62
12.6
8.1
inr
1.2
1.2
0.34
58
578
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
52
258
2.11
5.62
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
83
486
1.82
5.57
2.0
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
426
3671
1.55
5.50
5.6
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
206
1535
1.52
5.34
4.2
3.0
mmol/l
6.4
6.5
0.07
168
1273
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
247
1913
1.49
5.31
4.1
3.4
ng/l
21.0
48.6
0.79
165
1252
(40768443) Skin Pathology biopsy report
49
244
2.10
5.26
1.4
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
197
1461
1.52
5.20
3.8
3.1
mg/l
353.6
378.9
0.03
126
825
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
212
1597
1.51
5.19
2.5
2.1
u/l
130.6
150.8
0.66
202
1497
(3022217) INR in Platelet poor plasma by Coagulation assay
92
569
1.73
5.12
38.0
22.8
inr
1.3
1.2
0.15
11
80
(36304419) Bacteria [Presence] in Urine
184
1353
1.52
5.03
3.8
2.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
214
2.14
5.02
1.6
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
75
441
1.80
4.96
2.0
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
274
1.98
4.81
1.9
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
572
5382
2.22
4.69
20.7
14.6
mmol/l
139.5
139.7
0.85
565
5229
(3018418) pH of Serum or Plasma
208
1597
1.46
4.51
4.2
3.5
ph
7.4
7.4
1.11
34
298
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
557
5203
1.92
4.48
20.3
13.0
mg/l
23.2
20.9
0.77
463
4058
(3045424) Erythrocytes [Presence] in Urine
22
82
2.75
4.46
1.2
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
572
5394
2.18
4.46
20.8
14.7
mmol/l
4.0
3.9
0.83
564
5230
(3030467) Casts [#/volume] in Urine by Automated count
182
1366
1.48
4.42
4.0
2.9
e6/l
0.3
0.5
1.31
147
1016
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
112
758
1.59
4.38
2.0
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
26
4.29
4.37
1.8
3.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
135
959
1.53
4.26
1.7
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
79
493
1.69
4.26
4.7
4.0
u/l
239.1
259.2
0.48
74
466
(3020682) Albumin/Creatinine [Ratio] in Urine
200
1538
1.45
4.26
4.5
3.8
mg/mmol
11.9
5.8
0.73
117
860
(40761511) CBC panel - Blood by Automated count
572
5408
2.12
4.19
17.8
12.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
243
1942
1.42
4.17
3.7
3.2
mmol/l
2.4
2.4
0.52
208
1686
(21494815) CD4 cells/100 lymphocytes in Specimen
11
28
3.98
3.99
1.8
1.6
—
49.8
—
0
5
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
116
816
1.52
3.81
3.6
2.5
e6/l
2.5
1.3
0.59
83
435
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
148
2.15
3.75
2.4
2.1
u/l
2140.9
3787.2
0.35
13
63
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
25
4.05
3.71
2.1
1.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
579
5525
2.21
3.70
21.5
15.0
umol/l
71.3
69.4
0.77
579
5525
(3003458) Phosphate [Moles/volume] in Serum or Plasma
88
586
1.59
3.68
7.4
3.9
mmol/l
1.1
1.0
0.18
82
523
(3013707) Erythrocyte sedimentation rate by Westergren method
449
4038
1.44
3.68
5.5
4.2
mm/h
14.3
12.4
1.74
414
3723
(3006315) Basophils [#/volume] in Blood
309
2611
1.38
3.67
7.4
5.4
e9/l
0.0
0.0
0.87
280
2247
(3019198) Lymphocytes [#/volume] in Blood
314
2663
1.37
3.63
7.3
5.4
e9/l
1.8
1.9
1.97
287
2335
(3001604) Monocytes [#/volume] in Blood
307
2596
1.37
3.61
7.4
5.3
e9/l
0.5
0.6
0.46
278
2236
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
124
2.23
3.59
2.8
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
190
1489
1.40
3.53
4.0
3.0
e6/l
24.4
59.5
1.54
158
1130
(3013115) Eosinophils [#/volume] in Blood
317
2708
1.36
3.43
7.6
5.7
e9/l
0.2
0.2
0.27
290
2368
(4034850)
30
148
2.08
3.36
18.1
9.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
223
1809
1.37
3.33
4.3
3.5
e6/l
47.0
82.2
1.38
173
1234
(3026389) Candida sp identified in Specimen by Organism specific culture
19
79
2.45
3.16
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
44
3.00
3.15
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
483
4447
1.43
3.10
5.3
4.4
pmol/l
15.0
14.8
0.98
445
4066
(3026493) Urate [Moles/volume] in Serum or Plasma
161
1258
1.38
2.99
2.7
2.4
umol/l
7386.3
5959.9
0.10
141
1082
(40760892) CBC W Ordered Manual Differential panel - Blood
152
1181
1.38
2.91
4.9
4.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
577
5542
1.95
2.91
13.7
10.2
u/l
23.8
23.5
0.22
565
5332
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
530
4985
1.52
2.88
4.4
3.9
mmol/l
1.3
1.2
2.03
482
4539
(3051651) Icteric interference index of Serum or Plasma
10
31
3.26
2.78
2.5
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
41
242
1.74
2.75
1.6
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
14
5.04
2.73
3.1
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
35
201
1.79
2.58
1.6
2.1
g/l
1.8
1.5
0.59
27
176
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
62
2.46
2.56
1.0
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
13
50
2.64
2.54
9.8
5.7
mg/l
13.5
12.8
0.09
13
44
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
527
4976
1.47
2.54
15.2
12.0
ml/min/173m2
79.8
80.3
0.21
457
4058
(3026782) Osmolality of Urine
125
961
1.38
2.53
3.3
2.6
mosm/kgh2o
479.3
515.1
1.21
109
825
(3023520) Reticulocytes [#/volume] in Blood
56
370
1.57
2.46
2.1
2.8
e9/l
73.4
74.0
0.04
45
286
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
155
1240
1.34
2.43
1.5
1.6
mg/l
0.8
1.0
1.16
118
947
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
515
4852
1.42
2.41
6.3
5.5
mmol/mol
39.5
39.3
0.13
477
4485
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
125
1.96
2.39
1.5
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
118
1.99
2.38
1.7
2.6
u/ml
0.3
0.4
1.10
11
72
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
75
536
1.46
2.29
2.1
1.8
—
—
—
0
0
(3035880) pH of Pleural fluid
8
23
3.51
2.27
1.3
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
30
3.03
2.15
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
138
1.85
2.12
1.7
2.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
43
2.59
2.10
1.9
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
99
756
1.37
2.09
2.8
2.1
umol/l
12.1
13.0
0.57
87
684
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
31
2.93
2.08
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
20
3.53
2.06
2.1
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
20
3.53
2.06
1.4
2.3
—
—
—
0
0
(4281824)
17
83
2.08
2.03
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
26
148
1.79
2.01
3.3
3.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
32
2.84
2.00
2.7
2.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
77
2.11
1.98
1.5
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
51
349
1.50
1.95
5.0
6.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
251
1.59
1.95
4.6
3.3
mmol/l
2.3
2.1
0.10
32
196
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
73
536
1.41
1.95
2.0
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
502
1.42
1.94
1.6
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
552
5306
1.48
1.93
5.5
4.9
mmol/l
2.8
2.8
0.78
504
4884
(3019225) pH of Specimen
74
547
1.40
1.90
3.6
4.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
124
994
1.31
1.90
1.7
1.7
nmol/l
1336.1
1216.0
0.71
98
724
(3027945) Reticulocytes/100 erythrocytes in Blood
69
505
1.41
1.88
2.9
2.6
%
2.0
1.9
0.31
60
447
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
68
497
1.42
1.87
1.9
1.5
%
1.4
1.3
0.13
59
438
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
40
2.53
1.84
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
40
263
1.56
1.84
4.6
3.4
ph
7.4
7.4
—
7
43
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
176
1.68
1.83
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
12
4.19
1.82
1.4
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
90
694
1.35
1.80
2.8
2.1
g/l
2.3
2.4
1.83
80
631
(3017181) Myelocytes/100 leukocytes in Blood
60
432
1.43
1.79
4.0
3.9
%
0.9
1.0
0.23
27
109
(3022145) Colonoscopy Study observation
79
597
1.37
1.79
1.4
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
177
1.67
1.79
1.2
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
642
1.36
1.78
3.0
2.2
%
22.2
21.6
0.17
71
535
(3007461) Platelets [#/volume] in Blood
587
5735
1.89
1.76
29.0
19.7
e9/l
265.3
261.8
0.64
578
5595
(3024731) MCV [Entitic volume]
587
5736
1.88
1.74
28.9
19.6
fl
91.5
91.1
1.62
581
5654
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
36
2.52
1.74
1.2
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
249
2191
1.23
1.74
2.0
2.0
pmol/l
99.6
98.1
0.17
130
1052
(42529406) Shigella sp [Presence] in Stool by Culture
29
179
1.65
1.73
1.2
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
587
5737
1.87
1.73
28.8
19.6
pg
30.3
30.2
1.16
581
5655
(3026361) Erythrocytes [#/volume] in Blood
587
5737
1.87
1.73
29.0
19.7
e12/l
4.3
4.4
1.80
578
5582
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
61
2.16
1.72
1.5
1.7
%
60.6
58.5
—
8
40
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
48
2.32
1.71
2.7
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
587
5738
1.87
1.71
29.0
19.7
e9/l
6.7
6.6
0.95
578
5577
(3000963) Hemoglobin [Mass/volume] in Blood
587
5739
1.86
1.69
29.2
19.8
g/l
131.3
131.9
0.52
581
5656
(3000494) Fungus identified in Specimen by Culture
82
631
1.35
1.67
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
50
353
1.45
1.67
3.5
2.7
e9/l
4.4
4.1
0.41
32
277
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
190
1.61
1.63
1.9
1.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
14
3.59
1.62
1.0
3.6
%
63.4
48.5
—
5
14
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
175
1.63
1.60
1.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
460
1.39
1.59
1.6
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
26
2.71
1.58
1.3
2.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
26
2.71
1.58
1.0
1.3
ug/l
4.5
6.3
—
7
20
(3051611) Lipemic interference index of Serum or Plasma
11
50
2.22
1.57
2.6
2.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
92
1.87
1.57
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
12
57
2.13
1.56
1.1
1.2
u/l
58.6
55.7
—
7
41
(3002032) Base excess in Venous blood by calculation
57
419
1.40
1.54
3.7
2.8
mmol/l
2.1
2.3
0.20
46
341
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
43
0.00
1.52
0.0
1.6
—
1.2
—
0
38
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
51
2.18
1.51
1.4
1.3
ug/l
4.5
2.9
—
6
42
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
86
678
1.31
1.50
1.7
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
187
1.58
1.48
5.0
3.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
125
1038
1.26
1.46
3.2
2.6
mmol/l
2.5
2.5
0.94
109
918
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
540
5211
1.35
1.45
5.0
4.4
mmol/l
4.8
4.8
1.29
498
4818
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
59
2.05
1.44
1.1
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
410
4345
0.82
1.41
20.8
16.0
%
13.8
13.7
1.50
400
4259
(3023199) Leukocytes [#/volume] in Pleural fluid
9
40
2.27
1.40
1.9
1.1
e6/l
767.6
1460.8
—
9
28
(44790048)
10
46
2.19
1.40
1.8
1.5
—
—
—
0
0
(44790047)
10
46
2.19
1.40
1.8
1.5
—
—
—
0
0
(44790049)
10
46
2.19
1.40
1.8
1.5
—
—
—
0
0
(44806118)
10
46
2.19
1.40
1.8
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
142
1.64
1.40
1.3
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
82
1.85
1.36
3.5
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
533
5142
1.31
1.36
5.4
4.5
mmol/l
5.9
5.8
1.21
493
4682
(3021960) Folate [Moles/volume] in Serum or Plasma
147
1253
1.23
1.35
1.5
1.5
nmol/l
22.8
22.2
0.14
125
1049
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
128
1.66
1.35
1.3
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
10
47
2.15
1.34
2.1
1.2
g/l
32.7
32.6
—
10
42
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
98
1.76
1.32
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
98
1.76
1.32
1.8
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
536
5179
1.31
1.31
4.8
4.3
mmol/l
1.5
1.6
1.92
488
4761
(3006462) Nitrate [Presence] in Urine
6
24
2.51
1.30
4.0
4.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
18
2.79
1.28
1.4
1.1
u/l
15.0
16.2
—
5
13
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
44
2.06
1.27
1.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
35
2.30
1.27
1.6
1.5
ug/l
14.5
21.4
—
8
35
(4010399)
53
400
1.36
1.26
1.6
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
524
5057
1.28
1.23
6.2
5.4
mu/l
2.0
2.1
0.19
485
4653
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
30
205
1.49
1.22
3.7
2.8
mmol/l
24.3
24.6
0.22
24
183
(3028707) Methadone [Presence] in Urine by Screen method
12
64
1.89
1.18
7.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
160
1822
0.83
1.18
2.9
2.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
40
293
1.39
1.15
1.4
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
111
1.64
1.13
2.7
2.0
g/l
125.6
129.0
0.20
11
83
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
58
1.91
1.12
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
40
2.01
1.12
1.1
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
26
176
1.50
1.12
1.4
1.2
u/ml
6.0
2.3
—
5
19
(1761482) Bacteria [#/volume] in Urine by Culture
7
138
0.50
1.11
1.9
4.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
81
1.75
1.09
1.5
1.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
253
2306
1.17
1.09
11.8
8.7
e9/l
0.0
0.0
0.54
219
1881
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
26
178
1.48
1.07
1.4
1.2
u/ml
2.7
11.6
—
6
32
(3045788) Cell count panel - Pleural fluid
7
33
2.13
1.06
1.6
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
67
1.81
1.05
1.5
1.6
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
5
22
2.28
1.03
1.2
1.3
—
1.0
—
0
5
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
68
549
1.27
1.03
4.2
2.1
umol/l
5.3
6.6
0.71
60
470
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
147
1287
1.19
1.03
2.7
2.2
mg/l
3.7
3.1
1.80
125
1077
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
47
1.93
1.02
2.2
3.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
29
206
1.43
1.00
1.3
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
81
670
1.24
1.00
2.1
2.1
ug/g
240.7
115.8
0.56
56
520
(3000492) Spirometry study
58
461
1.29
1.00
1.3
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
27
190
1.44
0.98
2.4
5.3
%
1.7
1.5
0.56
27
181
(3016879) Cocaine [Presence] in Urine
18
116
1.57
0.97
5.2
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
100
1.62
0.97
3.1
2.4
ug/min
32.9
56.9
—
7
60
(3000012) Reticulocyte production index
0
30
0.00
0.97
0.0
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
52
409
1.30
0.97
4.4
4.0
%
0.1
0.1
0.09
21
99
(3000330) Specific gravity of Urine by Test strip
18
270
0.66
0.97
3.9
3.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
81
673
1.24
0.97
3.9
4.5
%
33.1
33.9
0.22
52
430
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
120
1038
1.19
0.96
1.3
1.3
u/ml
6.3
11.5
0.56
50
393
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
158
1.47
0.95
1.1
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
456
1.28
0.94
4.1
3.0
ng/l
92.5
76.8
0.84
52
396
(46235355) HIV 1 and 2 tests - Meaningful Use set
92
778
1.22
0.93
2.1
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
27
2.23
0.93
1.0
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
50
394
1.29
0.93
4.3
4.0
%
0.0
1.1
0.55
17
83
(3023419) Bacteria identified in Sputum by Culture
10
55
1.83
0.92
5.5
2.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
185
1665
1.16
0.92
4.4
2.8
u/l
30.9
28.8
0.49
170
1587
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
264
2438
1.15
0.92
2.4
2.3
nmol/l
81.1
78.8
0.60
227
2174
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
118
1.54
0.92
1.3
1.2
—
—
—
0
0
(4211845)
6
28
2.15
0.91
4.0
3.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
48
378
1.29
0.90
3.4
3.2
pmol/l
4.5
4.5
0.06
41
328
(3017704) Immunofixation for Urine
6
29
2.08
0.89
1.3
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
111
1.55
0.88
1.5
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
87
1.62
0.88
1.0
1.1
—
15.6
—
0
6
(3027008) Opiates [Presence] in Urine
19
128
1.50
0.87
5.1
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
44
1.83
0.86
2.5
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
257
2380
1.14
0.84
2.9
2.8
ug/l
116.8
90.6
1.15
234
2187
(3028300) Cannabinoids [Presence] in Urine
19
129
1.49
0.84
5.1
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
302
1.31
0.83
1.5
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
46
1.75
0.82
1.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
97
1.56
0.82
9.1
3.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
89
1.59
0.82
1.6
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.81
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
123
1085
1.17
0.79
1.8
1.5
g/l
2.1
2.2
0.16
68
637
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
33
1.83
0.79
1.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
296
1.30
0.79
1.1
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
141
1.43
0.75
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
54
1.68
0.74
1.6
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
29
219
1.34
0.74
3.6
2.3
u/l
40.4
40.7
0.02
23
193
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.73
1.9
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
100
1.51
0.73
5.9
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
39
1.80
0.72
1.1
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
39
1.80
0.72
1.1
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
39
1.80
0.72
1.1
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
120
1065
1.16
0.72
1.4
1.3
iu/ml
24.4
31.2
0.44
32
358
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
68
1.63
0.72
1.2
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
26
1.93
0.70
4.6
3.5
u/ml
486.6
1525.2
—
5
26
(3001019) Free T4 and TSH panel - Serum or Plasma
42
338
1.26
0.70
1.9
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
85
1.54
0.69
2.1
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
59
1.53
0.68
2.4
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
170
1.37
0.68
1.4
1.4
miu/ml
290.8
236.7
0.33
12
80
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
119
1.44
0.67
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
136
1.41
0.67
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
18
128
1.42
0.66
5.4
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
28
1.79
0.66
1.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
28
1.79
0.66
1.0
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
78
1.55
0.66
1.2
1.4
—
—
—
0
0
(4062490)
7
44
1.60
0.65
2.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
207
1.32
0.65
4.7
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
15
212
0.70
0.64
1.3
1.9
mg/l
3.3
4.9
—
10
157
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
132
1458
0.88
0.64
1.7
1.6
mmol/l
1.5
1.4
0.81
107
1232
(3019069) Monocytes/100 leukocytes in Blood
261
2452
1.11
0.64
8.4
5.8
%
8.3
8.3
0.05
247
2275
(3002030) Lymphocytes/100 leukocytes in Blood
266
2503
1.11
0.63
8.2
5.6
%
27.3
28.8
1.36
252
2313
(3003327) Ova and parasites identified in Stool by Light microscopy
13
188
0.68
0.63
1.7
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
263
2475
1.11
0.62
7.8
5.4
%
58.1
56.8
0.88
249
2293
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
71
1.56
0.62
1.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
326
1.24
0.61
1.4
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
105
1.44
0.60
1.6
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
21
0.00
0.60
0.0
1.2
—
8.8
—
0
21
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
131
1.39
0.59
1.5
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
259
2442
1.11
0.58
8.1
5.4
%
2.9
2.7
0.37
246
2248
(3037756) Immunofixation for Serum or Plasma
15
106
1.43
0.58
1.3
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
35
1.72
0.58
1.3
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
35
1.72
0.58
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
36
1.67
0.57
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
36
1.67
0.57
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
37
1.63
0.55
1.7
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
442
1.19
0.55
1.2
1.2
iu/ml
94.1
157.0
1.11
22
190
(3002179) Metamyelocytes/100 leukocytes in Blood
47
396
1.20
0.54
4.3
3.8
%
0.1
0.7
3.02
14
78
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
59
509
1.18
0.53
3.3
3.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
91
1.44
0.53
2.0
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
39
1.54
0.53
2.7
2.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
63
1.43
0.52
1.6
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
203
0.73
0.52
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.6
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
75
1.48
0.51
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
213
0.74
0.51
1.0
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
28
225
1.26
0.50
2.5
2.1
%
1.2
1.1
0.23
28
225
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
41
1.47
0.50
1.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
41
1.47
0.50
1.5
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
289
1.22
0.50
1.5
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
249
2359
1.09
0.50
8.3
5.5
%
0.7
0.7
0.82
235
2171
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
67
1.50
0.50
1.4
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
14
101
1.40
0.50
3.2
7.8
mmol/l
11.9
10.7
0.80
14
93
(3018572) Chloride [Moles/volume] in Blood
14
101
1.40
0.50
3.2
7.8
mmol/l
106.3
105.6
0.18
14
93
(3037522) Nuclear Ab [Titer] in Serum
87
779
1.14
0.49
1.6
1.3
titre
640.0
574.3
0.10
23
184
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
46
1.53
0.48
1.0
1.1
—
—
—
0
0
(4024509)
7
46
1.53
0.48
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
36
429
0.83
0.48
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
137
1.32
0.47
2.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
43
365
1.19
0.47
3.5
3.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
35
291
1.22
0.47
3.3
2.6
g/l
121.1
128.1
1.23
35
286
(3009445) Proteinase 3 Ab [Units/volume] in Serum
25
200
1.26
0.47
1.4
1.8
—
11.6
—
0
6
(3021901) Oxygen saturation in Capillary blood
12
85
1.42
0.47
4.1
2.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
48
1.46
0.47
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
352
3394
1.09
0.46
3.9
2.9
u/l
59.1
43.2
1.05
327
3138
(3027944) Amphetamines [Presence] in Urine
17
129
1.33
0.46
5.7
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
183
1716
1.10
0.45
8.4
5.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
372
0.82
0.45
1.8
2.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
123
1134
1.11
0.43
1.6
1.7
pmol/l
453.1
35599153.6
1.56
102
927
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
12
162
0.74
0.43
1.3
2.2
g/l
33.6
37.9
—
7
147
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
540
1.14
0.42
3.3
3.6
ug/l
3.2
9.1
3.11
51
432
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.0
—
97.8
—
0
8
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
16
0.00
0.41
0.0
1.0
—
107.5
—
0
8
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
168
1.26
0.40
1.2
1.4
ug/g
321.3
315.0
—
10
93
(3003740) Influenza virus B Ag [Presence] in Specimen
12
88
1.37
0.40
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
88
1.37
0.40
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
43
372
1.17
0.40
2.3
2.8
ng/l
245.7
172.6
0.38
37
345
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
71
1.42
0.39
1.0
1.3
—
—
—
0
0
(4027681)
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
66
1.37
0.38
1.6
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
66
1.37
0.38
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
66
1.37
0.38
1.6
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
36
1.39
0.38
1.8
1.8
mmol/l
6.0
6.9
—
5
25
(40768806) Pleura Pathology biopsy report
5
37
1.35
0.37
2.8
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
748
1.11
0.36
4.2
2.7
e6/l
3.7
4.7
0.49
49
370
(3019230) Fractional oxyhemoglobin in Venous blood
9
71
1.27
0.36
3.7
1.6
%
62.7
58.0
—
9
71
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
18
144
1.26
0.35
1.8
1.8
ug/l
148.2
172.0
0.22
18
127
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
43
1.40
0.35
1.0
1.1
mg/l
20.4
25.9
—
6
36
(21494434) Karyotype in Bone marrow
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
136
1.26
0.34
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
100
1.31
0.34
3.6
2.3
%
15.6
16.1
—
8
52
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
229
1.19
0.32
4.8
7.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
18
146
1.24
0.32
3.3
6.8
mmol/l
1.4
1.3
0.33
18
131
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
74
1.36
0.32
1.5
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
52
1.35
0.31
1.4
5.8
mmol/l
6.3
6.9
—
7
41
(4268621)
7
53
1.32
0.31
2.0
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
429
0.88
0.29
1.7
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
56
1.25
0.29
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
46
412
1.13
0.29
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
50
452
1.12
0.27
4.3
3.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
66
1.21
0.27
3.8
2.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
71
0.70
0.26
1.0
1.0
—
0.6
—
0
25
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
64
589
1.10
0.26
1.6
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
114
1.23
0.25
2.6
3.4
mg/l
19.0
20.8
—
7
68
(3019832) Treponema pallidum Ab [Presence] in Serum
45
407
1.11
0.25
1.6
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
46
417
1.11
0.25
1.9
3.0
g/l
63.1
67.5
1.91
38
380
(3009466) Valproate [Moles/volume] in Serum or Plasma
10
78
1.29
0.24
5.2
5.3
umol/l
315.5
389.4
—
10
67
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
106
1.23
0.23
4.5
3.3
e9/l
3.4
4.4
1.77
13
106
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
79
1.27
0.22
1.2
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
102.8
—
0
11
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
5.0
—
0
10
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
154
1.17
0.21
1.9
1.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
1.6
—
0
12
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.4
—
0.5
—
0
7
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
105
0.76
0.21
1.4
2.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
108
1.21
0.20
4.8
3.6
%
56.9
59.1
0.26
13
108
(36660697) Celiac disease serology panel - Serum
41
447
0.91
0.19
1.3
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
58
1.21
0.18
1.7
2.2
%
90.2
90.0
—
7
58
(3005570) Glucose [Moles/volume] in Urine
7
62
1.13
0.17
1.9
2.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
82
1.22
0.17
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
67
0.74
0.17
1.8
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
69
1.16
0.16
1.0
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
193
0.88
0.16
1.5
2.3
g/l
7.2
10.1
—
9
169
(3013512) EKG study
157
1522
1.04
0.15
4.0
3.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
78
1.16
0.15
1.2
1.2
nmol/l
—
—
—
0
0
(4094501)
12
140
0.85
0.15
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
118
0.84
0.14
1.4
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
85
814
1.05
0.14
1.1
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
15
170
0.88
0.14
2.4
2.7
g/l
1.2
1.0
—
9
154
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
209
1.10
0.13
1.5
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
85
1.18
0.12
1.0
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
282
0.92
0.12
2.4
2.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
444
1.06
0.12
5.8
3.5
mmol/l
1.2
1.2
1.07
38
381
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
12
137
0.87
0.12
1.3
1.2
mmol/l
3.6
3.8
0.65
12
127
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
199
0.90
0.11
2.0
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
199
0.90
0.11
2.0
2.3
g/l
7.5
7.6
—
8
158
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
302
0.92
0.11
1.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
327
3227
1.03
0.11
3.2
3.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
124
1.13
0.11
1.4
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
198
0.91
0.11
2.0
2.3
g/l
3.8
3.7
—
8
154
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
56
1.07
0.08
1.3
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
47
491
0.95
0.08
3.0
2.2
u/l
29.1
33.2
0.65
37
407
(3014133) Dog dander IgE Ab [Units/volume] in Serum
6
57
1.05
0.08
1.2
1.0
—
2.5
—
0
17
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
113
0.88
0.08
1.5
5.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
185
0.92
0.08
2.1
2.3
g/l
3.1
3.1
—
8
155
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
74
1.08
0.07
3.5
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
76
1.05
0.07
1.1
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
285
1.06
0.06
1.4
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
471
4686
1.02
0.06
16.2
14.3
%
38.9
39.0
0.08
298
3328
(3050129) First trimester maternal screen panel - Serum or Plasma
13
141
0.92
0.05
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
20
210
0.95
0.03
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
129
0.93
0.03
2.1
2.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
1275
1.01
0.03
1.3
1.3
u/ml
0.8
1.9
1.61
27
328
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
169
0.95
0.03
1.7
1.8
iu/l
2.1
5.8
—
6
55
(3037121) Protein [Mass/volume] in Urine
18
171
1.05
0.03
3.2
2.8
g/l
0.1
0.2
—
7
51
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
947
0.99
0.01
3.5
3.8
ng/l
80.4
364.5
2.02
66
702
(3041096) Erythrocytes [Presence] in Urine by Automated
146
1454
1.01
0.00
3.9
3.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
95
1.05
0.00
5.3
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
115
1.04
0.00
1.6
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
106
1.04
0.00
1.9
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
98
1.02
0.00
1.3
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
162
0.99
0.00
1.7
1.6
—
182.9
—
0
7
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
99
1.01
0.00
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
101
0.99
0.00
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
119
1.01
0.00
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
119
1.01
0.00
1.3
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(4306422)
7
72
0.97
0.00
1.3
1.1
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
117.1
—
0
8
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
68
0.88
0.00
1.7
2.2
mmol/l
104.3
105.6
—
6
68
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
2.6
—
0.7
—
0
7
(3016018) Differential panel - Cerebral spinal fluid
5
57
0.88
0.00
1.6
1.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
101.0
—
0
5
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
120
1.00
0.00
1.2
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
84
0.95
0.00
2.3
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
79
0.88
0.00
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
150
1.00
0.00
1.3
1.3
mg/l
434.0
485.0
0.30
15
138
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
10.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
67
0.89
0.00
1.3
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
66
0.91
0.00
1.5
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
120
1.00
0.00
1.2
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
57
0.88
0.00
1.0
1.9
pg
30.2
31.8
—
5
57
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
68
0.88
0.00
1.7
2.2
mmol/l
3.9
4.0
—
6
68
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.0
—
1.9
—
0
13
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
86
0.93
0.00
2.4
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
49
1.02
0.00
1.4
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
76.1
—
0
8
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_GENITAL – Carcinoma in situ of other and unspecified genital organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).